WallStreetZenWallStreetZen

NASDAQ: AWH
Aspira Women's Health Inc Stock Forecast, Predictions & Price Target

Analyst price target for AWH

Based on 1 analyst offering 12 month price targets for Aspira Women's Health Inc.
Min Forecast
$3.30-5.71%
Avg Forecast
$3.30-5.71%
Max Forecast
$3.30-5.71%

Should I buy or sell AWH stock?

Based on 1 analyst offering ratings for Aspira Women's Health Inc.
Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AWH stock forecasts and price targets.

AWH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-10

1 of 1

Forecast return on equity

Is AWH forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is AWH forecast to generate an efficient return on assets?
Company
N/A
Industry
3.15%

AWH revenue forecast

What is AWH's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.7M+16.89%
Avg 2 year Forecast
$13.3M+45.29%
AWH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AWH revenue growth forecast

How is AWH forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
16.89%
Industry
2.42%
Market
13.29%
AWH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AWH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AWH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
AWH$3.50$3.30-5.71%Hold
PRE$3.68$9.00+144.57%Strong Buy
DRIO$1.32$4.00+203.03%Strong Buy
VNRX$0.60$3.50+483.33%Strong Buy
BIAF$3.00N/AN/A

Aspira Women's Health Stock Forecast FAQ

Is Aspira Women's Health Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AWH) stock is to Hold AWH stock.

Out of 1 analyst, 0 (0%) are recommending AWH as a Strong Buy, 0 (0%) are recommending AWH as a Buy, 1 (100%) are recommending AWH as a Hold, 0 (0%) are recommending AWH as a Sell, and 0 (0%) are recommending AWH as a Strong Sell.

If you're new to stock investing, here's how to buy Aspira Women's Health stock.

What is AWH's revenue growth forecast for 2024-2025?

(NASDAQ: AWH) Aspira Women's Health's forecast annual revenue growth rate of 16.89% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 2.42%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.29%.

Aspira Women's Health's revenue in 2024 is $9,154,000.On average, 1 Wall Street analysts forecast AWH's revenue for 2024 to be $132,081,913, with the lowest AWH revenue forecast at $132,081,913, and the highest AWH revenue forecast at $132,081,913.

In 2025, AWH is forecast to generate $164,176,583 in revenue, with the lowest revenue forecast at $164,176,583 and the highest revenue forecast at $164,176,583.

What is AWH's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: AWH) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.15%.

What is AWH's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AWH price target, the average AWH price target is $3.30, with the highest AWH stock price forecast at $3.30 and the lowest AWH stock price forecast at $3.30.

The Wall Street analyst predicted that Aspira Women's Health's share price could fall to $3.30 by Apr 10, 2025. The average Aspira Women's Health stock price prediction forecasts a potential downside of 5.71% from the current AWH share price of $3.50.

What is AWH's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: AWH) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.